Skip to main content
SpringerLink
Log in

Reoperation for Bladder Cancer

  • Chapter
  • First Online:
Reoperative Pelvic Surgery

  • 827 Accesses

Abstract

Bladder cancer remains a significant health problem, with 67,160 new cases expected in 2007.1 Bladder cancer disproportionately affects men and persons greater than 65 years of age. This year 50,040 men and 17,120 women will be diagnosed; 9630 men and 4120 women will die from their disease.1 Bladder cancer is a complex disease, imparting a wide range of cancer risk to patients, resulting in a wide spectrum of treatments. Nearly 70% of tumors present at an early stage2 (Ta, Tis, or T1), the majority of which may be initially treated with transurethral resection with or without intravesical chemotherapy or immunotherapy depending on tumor and patient characteristics. Reoperation for early-stage bladder cancer generally results from complications from the endoscopic resection, covered fully in Chapter 17 of this text.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.

    Article  PubMed  Google Scholar 

  2. Greene FL, American Joint Committee on Cancer, American Cancer Society. American Joint Committee on Cancer. Urinary Bladder. In: AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag; 2002:367–73; xiv.

    Google Scholar 

  3. Hautmann RE, Gschwend JE, de Petriconi RC, et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol. 2006;176(2):486–92.

    Article  PubMed  Google Scholar 

  4. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75.

    CAS  PubMed  Google Scholar 

  5. Lee CT, Dunn RL, Chen BT, et al. Impact of body mass index on radical cystectomy. J Urol. 2004;172(4 Pt 1):1281–5.

    Article  PubMed  Google Scholar 

  6. Balaji KC, McGuire M, Grotas J, et al. Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J Urol. 1999;162(5):1603–6.

    Article  CAS  PubMed  Google Scholar 

  7. Huguet-Perez J, Palou J, Millan-Rodriguez F, et al. Upper tract transitional cell carcinoma following cystectomy for bladder cancer. Eur Urol. 2001;40(3):318–23.

    Article  CAS  PubMed  Google Scholar 

  8. Kenworthy P, Tanguay S, Dinney CP. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol. 1996;155(2):501–3.

    Article  CAS  PubMed  Google Scholar 

  9. Sved PD, Gomez P, Nieder AM, et al. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors. B J U Int. 2004;94(6):785–9.

    Google Scholar 

  10. Bochner BH, Montie JE, Lee CT. Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am. 2003;30(4):777–89.

    Article  PubMed  Google Scholar 

  11. Kuroda M, Meguro N, Maeda O, et al. Stage specific follow-up strategy after cystectomy for carcinoma of the bladder. Int J Urol. 2002;9(3):129–33.

    Article  PubMed  Google Scholar 

  12. Slaton JW, Swanson DA, Grossman HB, et al. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 1999;162 (3 Pt 1):710–4.

    Article  CAS  PubMed  Google Scholar 

  13. Hastie KJ, Hamdy FC, Collins MC, et al. Upper tract tumours following cystectomy for bladder cancer. Is routine intravenous urography worthwhile? Br J Urol. 1991;67(1):29–31.

    Article  CAS  PubMed  Google Scholar 

  14. Canfield SE, Dinney CP, Droller MJ. Surveillance and management of recurrence for upper tract transitional cell carcinoma. Urol Clin North Am. 2003;30(4):791–802.

    Article  PubMed  Google Scholar 

  15. Browne RF, Meehan CP, Colville J, et al. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics. 2005;25(6):1609–27.

    Article  PubMed  Google Scholar 

  16. Clark PE, Stein JP, Groshen SG, et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol. 2004;172(4 Pt 1):1342–7.

    Article  PubMed  Google Scholar 

  17. Freeman JA, Esrig D, Stein JP, et al. Management of the patient with bladder cancer. Urethral recurrence. Urol Clin North Am. 1994;21(4):645–51.

    CAS  PubMed  Google Scholar 

  18. Studer UE, Zingg EJ. Ileal orthotopic bladder substitutes. What we have learned from 12 years' experience with 200 patients. Urol Clin North Am. 1997;24(4):781–93.

    Article  CAS  PubMed  Google Scholar 

  19. Shelfo SW, Soloway MS. The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder. World J Urol. 1997;15(2):107–11.

    Article  CAS  PubMed  Google Scholar 

  20. Keir JA, Womack C. Sensitivity and specificity of urine cytology in the screening of transitional cell carcinomas. Cytopathology. 2002;13(6):381–2.

    Article  PubMed  Google Scholar 

  21. Xia TL. Cytologic diagnostic value of voided urine in 60 cases of primary transitional cell carcinoma of the renal pelvis and ureter. Zhonghua Wai KeZa Zhi. 1989;27(12):753–5, 782.

    CAS  Google Scholar 

  22. Bian Y, Ehya H, Bagley DH. Cytologic diagnosis of upper urinary tract neoplasms by ureteroscopic sampling. Acta Cytol. 1995;39(4):733–40.

    CAS  PubMed  Google Scholar 

  23. Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA. 2006;295(3):299–305.

    Article  CAS  PubMed  Google Scholar 

  24. Moonen PM, Kiemeney LA, Witjes JA. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer. Eur Urol. 2005;48(6):951–6.

    Article  CAS  PubMed  Google Scholar 

  25. Halling KC, King W, Sokolova IA, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;164(5):1768–75.

    Article  CAS  PubMed  Google Scholar 

  26. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol. 2005;47(6):736–48.

    Article  PubMed  Google Scholar 

  27. Black PC, Brown GA, Dinney CP. Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer. J Clin Oncol. 2006;24(35):5528–35.

    Article  CAS  PubMed  Google Scholar 

  28. Malkowicz SB, Skinner DG. Development of upper tract carcinoma after cystectomy for bladder carcinoma. Urology. 1990;36(1):20–2.

    Article  CAS  PubMed  Google Scholar 

  29. Fleshner N, Garland J, Moadel A, et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer. 1999;86(11):2337–45.

    Article  CAS  PubMed  Google Scholar 

  30. Strong DW, Pearse HD. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract. Cancer. 1976;38(5):2173–83.

    Article  CAS  PubMed  Google Scholar 

  31. Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology. 1998;52(4):594–601.

    Article  CAS  PubMed  Google Scholar 

  32. Roupret M, Hupertan V, Traxer O, et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology. 2006;67(6):1181–7.

    Article  PubMed  Google Scholar 

  33. Jabbour MSA. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol Clin North Am. 2000;27:739–50.

    Article  CAS  PubMed  Google Scholar 

  34. Thalmann GN, Markwalder R, Walter B, et al. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol. 2002;168(4 Pt 1):1381–5.

    PubMed  Google Scholar 

  35. Gill IS, Sung GT, Hobart MG, et al. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience. J Urol. 2000;164(5):1513–22.

    Article  CAS  PubMed  Google Scholar 

  36. Hattori R, Yoshino Y, Gotoh M, et al. Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience. Urology. 2006;67(4):701–5.

    Article  PubMed  Google Scholar 

  37. Chung SD HC, Chueh SC, Pu YS, et al. Intermediate follow-up of hand-assisted retroperitoneoscopic nephroureterectomy for management of upper urinary tract urothelial carcinoma: comparison with open nephroureterectomy. Urology. 2007;69(6):1030–4.

    Article  PubMed  Google Scholar 

  38. Seifman B, Montie, JE, Wolf, JS. Prospective comparison between hand-assisted laparoscopic and open surgical nephroureterectomy for urothelial cell carcinoma. Urology. 2001;57(1):133–7.

    Article  CAS  PubMed  Google Scholar 

  39. Hardeman SW, Soloway MS. Urethral recurrence following radical cystectomy. J Urol. 1990;144(3):666–9.

    CAS  PubMed  Google Scholar 

  40. Zincke H, Garbeff PJ, Beahrs JR. Upper urinary tract transitional cell cancer after radical cystectomy for bladder cancer. J Urol. 1984;131(1):50–2.

    CAS  PubMed  Google Scholar 

  41. Stein JP, Clark P, Miranda G, et al. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol. 2005;173(4):1163–8.

    Article  PubMed  Google Scholar 

  42. Stenzl A, Bartsch G, Rogatsch H. The remnant urothelium after reconstructive bladder surgery. Eur Urol. 2002;41(2):124–31.

    Article  PubMed  Google Scholar 

  43. Bell CR, Gujral S, Collins CM, et al. Review. The fate of the urethra after definitive treatment of invasive transitional cell carcinoma of the urinary bladder. B J U Int. 1999;83(6):607–12.

    CAS  Google Scholar 

  44. Levinson AK, Johnson DE, Wishnow KI. Indications for urethrectomy in an era of continent urinary diversion. J Urol. 1990;144(1):73–5.

    CAS  PubMed  Google Scholar 

  45. Raz S, McLorie G, Johnson S, et al. Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma. J Urol. 1978;120(3):298–300.

    CAS  PubMed  Google Scholar 

  46. Sorscher S, Islam R, Mason A. Urethral 'recurrence' found 14 years after radical cystectomy. Int J Urol. 2004;11(7):567–9.

    Article  PubMed  Google Scholar 

  47. Tongaonkar HB, Dalal AV, Kulkarni JN, et al. Urethral recurrences following radical cystectomy for invasive transitional cell carcinoma of the bladder. Br J Urol. 1993;72(6):910–4.

    Article  CAS  PubMed  Google Scholar 

  48. Tobisu K, Tanaka Y, Mizutani T, et al. Transitional cell carcinoma of the urethra in men following cystectomy for bladder cancer: multivariate analysis for risk factors. J Urol. 1991;146(6):1551–3.

    CAS  PubMed  Google Scholar 

  49. Freeman JA, Tarter TA, Esrig D, et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol. 1996;156(5):1615–9.

    Article  CAS  PubMed  Google Scholar 

  50. Tobisu K, Kanai Y, Sakamoto M, et al. Involvement of the anterior urethra in male patients with transitional cell-carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy. Jpn J Clin Oncol. 1997;27(6):406–9.

    Article  CAS  PubMed  Google Scholar 

  51. Richie JP, Skinner DG. Carcinoma in situ of the urethra associated with bladder carcinoma: the role of urethrectomy. J Urol. 1978;119(1):80–1.

    CAS  PubMed  Google Scholar 

  52. Lebret T, Herve JM, Barre P, et al. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy. Eur Urol. 1998;33(2):170–4.

    Article  CAS  PubMed  Google Scholar 

  53. Stein JP, Cote RJ, Freeman JA, et al. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: A pathological review of female cystectomy specimens. J Urol. 1995;154(4):1329–33.

    Article  CAS  PubMed  Google Scholar 

  54. Varol C, Thalmann GN, Burkhard FC, et al. Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution. J Urol. 2004;172(3):937–42.

    Article  PubMed  Google Scholar 

  55. Hickey DP, Soloway MS, Murphy WM. Selective urethrectomy following cystoprostatectomy for bladder cancer. J Urol. 1986;136(4):828–30.

    CAS  PubMed  Google Scholar 

  56. Lin DW, Herr HW, Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol. 2003;169(3):961–3.

    Article  PubMed  Google Scholar 

  57. Erckert M, Stenzl A, Falk M, et al. Incidence of urethral tumor involvement in 910 men with bladder cancer. World J Urol. 1996;14(1):3–8.

    Article  CAS  PubMed  Google Scholar 

  58. Baskin LS, Turzan C. Carcinoma of male urethra: management of locally advanced disease with combined chemotherapy, radiotherapy, and penile-preserving surgery. Urology. 1992;39(1):21–5.

    Article  CAS  PubMed  Google Scholar 

  59. Gheiler EL, Tefilli MV, Tiguert R, et al. Management of primary urethral cancer. Urology. 1998;52(3):487–93.

    Article  CAS  PubMed  Google Scholar 

  60. Dalbagni G, Zhang ZF, Lacombe L, et al. Male urethral carcinoma: analysis of treatment outcome. Urology. 1999;53(6):1126–32.

    Article  CAS  PubMed  Google Scholar 

  61. Scher HI, Yagoda A, Herr HW, et al. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. J Urol. 1988;139(3):475–7.

    CAS  PubMed  Google Scholar 

  62. Zeidman EJ, Desmond P, Thompson IM. Surgical treatment of carcinoma of the male urethra. Urol Clin North Am. 1992;19(2):359–72.

    CAS  PubMed  Google Scholar 

  63. Dinney CP, Johnson DE, Swanson DA, et al. Therapy and prognosis for male anterior urethral carcinoma: an update. Urology. 1994;43(4):506–14.

    Article  CAS  PubMed  Google Scholar 

  64. Naitoh J, Aronson, William J., and DeKernion, Jean B. Urethral cancer in women. In: Grahahm SD Jr., ed. Glenn's Urologic Surgery, 5th ed. Philadelphia: Lippincott-Raven; 1998:463.

    Google Scholar 

  65. Aronson WJ, Naitoh, John, and deKernion, Jean B. Carcinoma of the Male Urethra. In: Grahahm SD Jr., ed. Glenn's Urologic Surgery. Philadelphia: Lippincott-Raven; 1998:470.

    Google Scholar 

  66. Spiess PE, Kassouf W, Brown G, et al. Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: Is there a benefit to either approach? Urology. 2006;67(3):466–71.

    Article  PubMed  Google Scholar 

  67. Hollenbeck BK, Taub DA, Dunn RL, Wei JT. Quality of care: partial cystectomy for bladder cancer–a case of inappropriate use? J Urol. 2005;174(3):1050–4.

    Article  PubMed  Google Scholar 

  68. Holzbeierlein JM, Lopez-Corona E, Bochner BH, et al. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol. 2004;172(3):878–81.

    Article  PubMed  Google Scholar 

  69. Kassouf W, Swanson D, Kamat AM, et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: A contemporary review of the M. D. Anderson Cancer Center experience. J Urol. 2006;175(6):2058–62.

    Article  PubMed  Google Scholar 

  70. Sweeney P, Kursh ED, Resnick MI. Partial cystectomy. Urol Clin North Am. 1992;19(4):701–11.

    CAS  PubMed  Google Scholar 

  71. Marshall FF. Radical Cystectomy. In: Marshall FF, ed. Textbook of Operative Urology. Philadelphia: WB Saunders; 1996.

    Google Scholar 

  72. Faysal MH, Freiha FS. Evaluation of partial cystectomy for carcinoma of bladder. Urology. 1979;14(4):352–6.

    Article  CAS  PubMed  Google Scholar 

  73. Merrell RW, Brown HE, Rose JF. Bladder carcinoma treated by partial cystectomy: A review of 54 cases. J Urol. 1979;122(4):471–2.

    CAS  PubMed  Google Scholar 

  74. Greven KM, Spera JA, Solin LJ, et al. Local recurrence after cystectomy alone for bladder carcinoma. Cancer. 1992;69(11):2767–70.

    Article  CAS  PubMed  Google Scholar 

  75. Honma I, Masumori N, Sato E, et al. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology. 2004;64(4):744–8.

    Article  PubMed  Google Scholar 

  76. Hautmann RE, Simon J. Ileal neobladder and local recurrence of bladder cancer: patterns of failure and impact on function in men. J Urol. 1999;162(6):1963–6.

    Article  CAS  PubMed  Google Scholar 

  77. Westney OL, Pisters LL, Pettaway CA, et al. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 1998;159(3):792–5.

    Article  CAS  PubMed  Google Scholar 

  78. von der Maase H, Sengelov L, Roberts JT, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23(21):4602–8.

    Article  PubMed  Google Scholar 

  79. Pollack A, Zagars GK, Cole CJ, et al. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol. 1995;154(6):2059–63.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Resident, Department of Urology, University of Michigan, Ann Arbor, MI, USA

    Rou Wang MD, Nina Casanova MD & Cheryl T. Lee (Associate Professor)

Authors
  1. Rou Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nina Casanova MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cheryl T. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Northwest Colon and Rectal Clinic, Madison Street 1101, Seattle, 98104, U.S.A.

    Richard P. Billingham

  2. Virginia Mason Medical Center, 9th Avenue 1100, Seattle, 98101, U.S.A.

    Kathleen C. Kobashi

  3. Madison Street 1100, Seattle, 98104, U.S.A.

    William A. Peters

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Wang, R., Casanova, N., Lee, C.T. (2009). Reoperation for Bladder Cancer. In: Billingham, R., Kobashi, K., Peters, W. (eds) Reoperative Pelvic Surgery. Springer, New York, NY. https://doi.org/10.1007/b14187_8

Download citation

  • DOI: https://doi.org/10.1007/b14187_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-89998-5

  • Online ISBN: 978-0-387-89999-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation